--(BUSINESS WIRE)--Dec. 21, 2012--
Celgene Corporation (NASDAQ: CELG)
today announced its
presentation at the 31st
Annual J.P. Morgan Healthcare
on January 7, 2013
at 11:00a.m. E.T.
will be webcast live and
will be available in the investor relations section of the company’s Web
site at www.celgene.com
management will provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for the
treatment of cancer and inflammatory diseases through gene and protein
regulation. For more information, please visit the company’s Web site at www.celgene.com.
Source: Celgene Corporation
Jacqualyn A. Fouse, Ph.D, 908-673-9956
Chief Financial Officer
Patrick E. Flanigan III,
VP, Investor Relations